Northrop Grumman Corporation

(New York Stock Exchange)
Somewhat Bearish -25

Northrop Grumman (NOC) Just Won Another Missile-Defense Contract. Why Does the Stock Still Trade at a Discount?

πŸ“‰ Northrop Grumman stock slipped 2.5% to $515 despite securing a $508.5 million MDA contract and ~$3 billion in framework agreements for solid-rocket-motor production.

πŸš€ The company holds significant exposure to the Golden Dome program through space sensors, interceptors, and the Sentinel ICBM system.

⚠️ The Sentinel ICBM program triggered a critical Nunn-McCurdy breach after projected costs surged 81% to roughly $141 billion, necessitating Pentagon restructuring.

πŸ’Έ Low-rate initial production on the B-21 bomber generated approximately $2 billion in pre-tax charges on fixed-price commitments.

πŸ“Š Northrop Grumman trades at about 16 times earnings, significantly lower than Lockheed Martin's 19x multiple and 33% below its peak price.

πŸ›‘οΈ The latest MDA contract includes cost-plus and cost-reimbursable elements to reduce financial exposure compared to purely fixed-price development work.

πŸ“‰ Institutional holdings decreased slightly from 62 hedge funds in Q1 2026 to 59 in Q2 2026, though short interest remains low at 1.7%.

πŸ” Management must demonstrate that losses from Sentinel and B-21 programs have ceased before the stock's multiple can expand significantly.

Bullish Signals
  • Northrop Grumman secured a $508.5 million Missile Defense Agency contract for ICBM and IRBM target flight-test support running through 2035.
  • The company has approximately $3 billion in framework agreements to expand solid-rocket-motor production for PAC-3 and THAAD interceptors.
  • Northrop Grumman received an additional $1.4 billion in IBCS-related U.S. and Polish air-and-missile-defense awards announced in 2025.
  • The latest MDA contract includes cost-plus, cost-reimbursable, and fixed-price-incentive elements which reduce some financial exposure compared with purely fixed-price development work.
  • Northrop Grumman offers portfolio diversification with a -0.11 beta and a 1.9% dividend yield.
Risk Factors
  • The Sentinel ICBM program triggered a critical Nunn-McCurdy breach after projected costs rose 81% to roughly $141 billion, forcing a Pentagon program restructuring.
  • Low-rate initial production on the B-21 bomber generated approximately $2 billion in pre-tax charges on fixed-price commitments.
  • Long-term missile-shield funding remains tied to both political and defense bets, introducing timing risk via legislative approval.
  • Further charges such as those incurred on Sentinel or the B-21 will keep the multiple depressed until losses cease.
Full Analysis
Northrop Grumman (NOC) secured a $508.5 million Missile Defense Agency contract on September 4, 2026, for ICBM and IRBM target flight-test support extending through 2035. This non-competitive award follows approximately $3 billion in framework agreements to expand solid-rocket-motor production for PAC-3 and THAAD interceptors, alongside $1.4 billion in IBCS-related awards announced previously. Despite these significant bookings, the stock slipped 2.5% to $515, trading near 16 times earnings and roughly 33% below its peak. The company remains one of the largest-cap defense contractors with exposure to the Golden Dome program via space sensors and interceptors, as well as the Sentinel ICBM and B-21 bomber programs. However, the stock trades at a discount compared to peers like Lockheed Martin due to execution problems in major developmental programs. Specifically, the Sentinel ICBM program triggered a critical Nunn-McCurdy breach after projected costs rose 81% to roughly $141 billion, forcing Pentagon restructuring. Concurrently, low-rate initial production on the B-21 bomber generated approximately $2 billion in pre-tax charges on fixed-price commitments. Management must demonstrate that these losses have ceased before multiple expansion can resume. While institutional positioning shows 59 hedge funds holding NOC in Q2 2026 and short interest remains low at 1.7%, the primary valuation driver is margin pressure and cost discipline on these major programs rather than contract volume alone.